Indefinite Delivery Contract 75F40123D00040
- Not listed
- The summary is as follows: The Department of Health and Human Services' Food and Drug Administration (FDA) has awarded an Indefinite Delivery Contract (IDC) worth up to $10 million to Molecular Epidemiology Inc., a for-profit, woman-owned small business. The contract is for microbiological analysis of FDA-regulated foods, agricultural water, and cosmetics. This includes tasks such as whole genome sequencing, pathogen testing, and epidemiological assessments to support the FDA's food safety and...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Molecular Epidemiology Inc. to provide microbiological analysis and whole genome sequencing services. The single award IDV has a potential value of $10 million and a period of performance through May 2027. Five firm fixed price task orders have been issued against the contract to date for specific services. These include analysis of Cyclospora cayetanensis oocysts, shrimp...
- This federal contract indefinite delivery vehicle (IDV) was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Molecular Epidemiology Inc., a for-profit, woman-owned small business. The single-award contract, valued at up to $10 million, is for microbiological analysis and whole genome sequencing of FDA-regulated food products, agricultural water, and cosmetic samples to support the FDA's food safety and public health missions. Under this IDV, the FDA...
- The Department of Health and Human Services Food and Drug Administration awarded an Indefinite Delivery Contract with a potential value of $25 million to Midnight Sun Technologies LLC. The contract is a single award, 8(a) sole source set aside for scientific support services to be performed across multiple locations including Silver Spring, MD, Vienna, VA, and Calverton, MD. The contract aims to procure subject matter expertise through various labor categories such as Scientist III, Researcher...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery, indefinite quantity contract to Koniag Management Solutions LLC with a potential value of $25,000,000. Task orders issued against the contract procure scientific support services including research, laboratory analysis, and subject matter expertise to support the FDA's regulatory, compliance and public health programs. Task orders awarded to Koniag Management Solutions LLC and described in...
- The Department of Health and Human Services Food and Drug Administration awarded a single award Indefinite Delivery Indefinite Quantity contract to Labstat International Inc. to provide tobacco laboratory analysis and engineering services. The contract has a potential value of $45 million over five one-year ordering periods. Three firm fixed price delivery orders have been awarded against the contract to date, including for new smoking regimen services generating and quantitating tobacco smoke...
- The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Propharma Group, LLC (doing business as Acadeus) with a potential value of $25 million. The contract provides review of Laboratory-Developed Tests and In Vitro Diagnostics Support through March 6, 2027. A $7.736 million firm fixed price delivery order was also awarded for the period of March 2, 2022 through September 6, 2024 in Silver Spring, Maryland. Under this delivery order,...
- This federal contract IDV was awarded by the Food and Drug Administration (FDA), a civilian agency, to Silliker, Inc., a foreign-owned for-profit organization. The single-award Indefinite Delivery Contract has a ceiling value of $3,146,417 and runs through September 14, 2015 under the "CHEMICAL ANALYSIS" program. Under this IDC, Silliker provides firm fixed-price analytical services to the FDA, including surveying food products for the presence of chemicals like 4-methylimidazole,...
- The Food and Drug Administration awarded a single-award Indefinite Delivery Contract valued at $50,000,000 to Tranquil Clinical and Research Consulting Services LLC (UEI: FWWJT8QCEDY4), effective September 15, 2025, through September 18, 2030. This contract, set aside for small businesses, supports the FDA's Office of Clinical Pharmacology through the provision of comprehensive clinical trial and laboratory support services. The contracted services encompass protocol development, clinical...
- The Food and Drug Administration awarded a single award indefinite delivery contract to Laboratory Corporation of America Holdings to provide COVID-19 testing services. Under the contract, two firm fixed price delivery orders were issued for a total value of $206,037. The first order is for testing 2,500 FDA Office of Regulatory Affairs employees for $190,775. The second order is for testing 200 Center for Tobacco Products personnel for $15,262. Both delivery orders have a period of...
- 75F40123D00040Indefinite Delivery Contract
- 3Federal Contract Awards
The Department of Health and Human Services Food and Drug Administration awarded a single-award indefinite delivery/indefinite quantity contract to Molecular Epidemiology Inc. with a potential value of $750,000. A firm fixed price delivery order for $225,600 was issued against the contract for sampling and analysis services in support of infant food testing to be performed in Silver Spring, Maryland from September 2023 through September 2024. The originating solicitation sought proposals for a contract to develop analytical survey capabilities to assess quantities of specified chemicals in foods, dietary supplements, and cosmetics. Samples would be collected across the United States from a range of product categories and analyzed for contaminants, additives, adulterants, nutrients, and naturally occurring components. Proposed methods were to comply with those established by the FDA's Center for Food Safety and Applied Nutrition. The contractor must maintain ISO/IEC 17025 accreditation throughout the period of performance to ensure reliable analytical results aid the agency's efforts to ensure public health and safety.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/26/23 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75F40123D00040-75F40125F19003 | Molecular Epidemiology Inc. | $60.6k | 8/19/25 | 9/27/26 | 8/19/25 | |
Delivery Order 75F40123D00040-75F40124F19002 | Molecular Epidemiology Inc. | $102.6k | 8/26/24 | 9/27/25 | 8/26/24 | |
Delivery Order 75F40123D00040-75F40123F19001 | Molecular Epidemiology Inc. | $225.6k | 9/29/23 | 9/29/24 | 9/29/23 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Contract for Sampling and Analysis | 75F40123D00040 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 2/2 | 10/3/23, 9:52 AM | |
Contract for Sampling and Analysis | FDA-23-SOL-116650A | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/2 | 9/5/23, 10:47 AM |